United States · FDA National Drug Code directory

Allergy relief-D

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51660-940_767603f0-b735-4513-97d9-6c69a0bf70e3
Product NDC
51660-940
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler
Ohm Laboratories Inc.
Marketing category
ANDA
Marketing start / end (source format)
20170502
Source listing expiry
20261231

Source-listed ingredients

  • CETIRIZINE HYDROCHLORIDE — 5 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 BLISTER PACK in 1 CARTON (51660-940-12) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 51660-940-12
  • 4 BLISTER PACK in 1 CARTON (51660-940-24) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 51660-940-24

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →